Novo Holdings A/S’s Xenon Pharmaceuticals XENE Stock Holding History

Novo Holdings A/S’s Portfolio XENE Stock Details XENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29.3M	Hold	485,438	–	–	1.7%	19
2026 Q1	$28.2M	Buy	+485,438	New	+$22.4M	2.29%	18
2017 Q3	–	Sell	-127,563	Closed	-$402K	–	18
2017 Q2	$402K	Hold	127,563	–	–	0.05%	21
2017 Q1	$510K	Hold	127,563	–	–	0.05%	21
2016 Q4	$982K	Hold	127,563	–	–	0.09%	21
2016 Q3	$1.03M	Hold	127,563	–	–	0.09%	16
2016 Q2	$753K	Hold	127,563	–	–	0.08%	17
2016 Q1	$892K	Hold	127,563	–	–	0.1%	17
2015 Q4	$1.03M	Hold	127,563	–	–	0.1%	14
2015 Q3	$1.05M	Hold	127,563	–	–	0.11%	19
2015 Q2	$1.47M	Hold	127,563	–	–	0.11%	19
2015 Q1	$2.15M	Hold	127,563	–	–	0.18%	14
2014 Q4	$2.52M	Buy	+127,563	New	+$1.87M	0.2%	15

Other funds holding XENE

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Novo Holdings A/S's XENE Position: Q2 2026 in Review

Novo Holdings A/S held its Xenon Pharmaceuticals (XENE) position steady in Q2 2026 at 485,438 shares worth $29.3M. The position accounts for 1.7% of the portfolio, ranked #19.

Novo Holdings A/S first reported a position in XENE in Q4 2014 and has held it in 13 quarters since. 316 funds tracked by Wall St. Rank hold XENE as of Q2 2026.

Novo Holdings A/S held 485,438 shares of Xenon Pharmaceuticals worth $29.3M as of Q2 2026.
Novo Holdings A/S left its Xenon Pharmaceuticals share count unchanged in Q2 2026.
Xenon Pharmaceuticals made up 1.7% of Novo Holdings A/S's portfolio in Q2 2026, its #19 holding.
Novo Holdings A/S first reported a position in Xenon Pharmaceuticals in Q4 2014 and has held it in 13 quarters since.
316 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q2 2026.

Based on Novo Holdings A/S's 13F filing for Q2 2026, filed 14 Aug 2026.